Use of the Poly (ADP-Ribose) Polymerase Inhibitor Rucaparib in Women with Recurrent Ovarian Carcinoma with Endometrioid and Other Nonserous Histopathologic Subtypes Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Leary, Alexandra; Ledermann, Jonathan A.; Oaknin, Ana; Oza, Amit M.; Lorusso, Domenica; Colombo, Nicoletta; Dean, Andrew; Clamp, Andrew; Scambia, Giovanni; Casado Herraez, Antonio; Amenedo Gancedo, Margarita; Maria Guerra, Eva; Balmana, Judith; Floquet, Anne; Fong, Peter C.; Holloway, Robert W.; Poelcher, Martin; Roxburgh, Patricia; Shapira-Frommer, Ronnie; Tamberi, Stefano; Tinker, Anna V.; Cameron, Terri; Maloney, Lara; Goble, Sandra; Kristeleit, Rebecca S.; Swisher, Elizabeth M.; McNeish, Iain A.; Coleman, Robert L.

authors

Publication Date

  • October 1, 2018

webpage

published in

category

keywords

  • PARP inhibitor
  • endometrial
  • ovarian cancer
  • rucaparib

start page

  • 200

end page

  • 201

volume

  • 28